Citation Impact
Citing Papers
Untangling the ErbB signalling network
2001 Standout
MCF-7 breast cancer cells overexpressing transfectedc-erbB-2 have anin vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivityin vivo
1995
Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors
1991
ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma
1996
Triplex formation inhibits HER-2/neu transcription in vitro.
1993
Feedback Regulation of β-Arrestin1 Function by Extracellular Signal-regulated Kinases
1999 StandoutNobel
EGFR Antagonists in Cancer Treatment
2008 Standout
Pancreatic cancer
2004 Standout
G Protein-Coupled Receptor Kinase Function Is Essential for Chemosensation in C. elegans
2004 StandoutNobel
The Role of the Epidermal Growth Factor Receptor Family in Mammary Tumorigenesis and Metastasis
1999
Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and Gsα Genes as a Cause of Toxic Thyroid Adenomas1
1997
Cushing’s Syndrome Secondary to Adrenocorticotropin-Independent Macronodular Adrenocortical Hyperplasia due to Activating Mutations ofGNAS1Gene
2003
Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor
1995 StandoutNatureNobel
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
The Thyroid Nodule
2004 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Germline mutations in the thyrotropin receptor gene cause non–autoimmune autosomal dominant hyperthyroidism
1994
Schizophrenia
2009 Standout
Cushing's syndrome
2015 Standout
BRAFE600-associated senescence-like cell cycle arrest of human naevi
2005 StandoutNature
Advanced pancreatic carcinoma: current treatment and future challenges
2010
Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives
2007
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Celiac Disease
2007 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Direct Binding of Activated c-Src to the β3-Adrenergic Receptor Is Required for MAP Kinase Activation
2000 StandoutNobel
The β2-Adrenergic Receptor Mediates Extracellular Signal-regulated Kinase Activation via Assembly of a Multi-receptor Complex with the Epidermal Growth Factor Receptor
2000 StandoutNobel
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Essential Role for G Protein-coupled Receptor Endocytosis in the Activation of Mitogen-activated Protein Kinase
1998 StandoutNobel
β-Arrestin1 Interacts with the Catalytic Domain of the Tyrosine Kinase c-SRC
2000 StandoutNobel
Non-B DNA conformations, mutagenesis and disease
2007
Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns
2010
Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status
1999
Mitogenic Signaling via G Protein-Coupled Receptors
1996 StandoutNobel
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Ras-dependent Mitogen-activated Protein Kinase Activation by G Protein-coupled Receptors
1997 StandoutNobel
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
1993 Nature
β-Arrestin-mediated Recruitment of the Src Family Kinase Yes Mediates Endothelin-1-stimulated Glucose Transport
2001 StandoutNobel
Activation of the Luteinizing Hormone Receptor Following Substitution of Ser-277 with Selective Hydrophobic Residues in the Ectodomain Hinge Region
2000 StandoutNobel
Generation of a functional mammary gland from a single stem cell
2006 StandoutNature
Serotonin 5-HT1A Receptor-mediated Erk Activation Requires Calcium/Calmodulin-dependent Receptor Endocytosis
1999 StandoutNobel
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Hsp70 and CHIP Selectively Mediate Ubiquitination and Degradation of Hypoxia-inducible Factor (HIF)-1α but Not HIF-2α
2009 StandoutNobel
G Protein-coupled Receptors
1998 StandoutNobel
Abnormalities of the RB1 and DCC tumor suppressor genes: Uncommon in human pancreatic adenocarcinoma
1995
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability
2016 StandoutNobel
Accuracy of Testing for Antibodies to Synthetic Gliadin–Related Peptides in Celiac Disease
2006
Expression and Activity of G Protein-Coupled Receptor Kinases in Differentiated Thyroid Carcinoma
2002
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Genetics and biology of pancreatic ductal adenocarcinoma
2006
Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop
1996 StandoutNobel
Pancreatic cancer
2011 Standout
Constitutively active receptors as a disease-causing mechanism
1994
Structural Instability of a Constitutively Active G Protein-coupled Receptor
1997 StandoutNobel
Cell senescence and cancer
2001
Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu
2002
Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation
2011 StandoutNobel
Identification of a Motif in the Carboxyl Terminus of β-Arrestin2 Responsible for Activation of JNK3
2001 StandoutNobel
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence
2003 Standout
Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation
2003 Standout
Activating Mutations of Gsα in Kidney Cancer
2006
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
AID-induced decrease in topoisomerase 1 induces DNA structural alteration and DNA cleavage for class switch recombination
2009 StandoutNobel
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
1993
Somatic and germline mutations of the TSH receptor gene in thyroid diseases.
1995
G PROTEIN–COUPLED RECEPTOR KINASES
1998 StandoutNobel
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
1992
Ligand-induced overexpression of a constitutively active β 2 -adrenergic receptor: Pharmacological creation of a phenotype in transgenic mice
1997 StandoutNobel
Histone3 lysine4 trimethylation regulated by the facilitates chromatin transcription complex is critical for DNA cleavage in class switch recombination
2010 StandoutNobel
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
1996 StandoutScience
Evaluation and Management of the Solid Thyroid Nodule
1995
Works of S Staddon being referenced
Association of the Dysbindin Gene With Bipolar Affective Disorder
2006
The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis
2006
Ki-ras oncogene activation in preinvasive pancreatic cancer
1992
Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer.
1990
Activating point mutations of the gsp oncogene in human thyroid adenomas
1991
Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene.
1990